Rubicon Organics disappoints: time to sell?
Rubicon Organics’ (Rubicon Organics Stock Quote, Chart, News, Analysts, Financials TSXV:ROMJ) slower-than-expected expansion of its Cascadia production facility has prompted Haywood Securities analyst Neal Gilmer to lower his earnings forecasts, although he continues to see growth opportunities in the premium cannabis market.
In a Nov. 16 report, Gilmer maintained his “Buy” rating and $1.30 target on the Vancouver-based cannabis producer, arguing that stronger production at its existing Pacifica facility should help offset delays at Cascadia.
“Rubicon’s third quarter results were generally below our expectations, with the ramp of the Cascadia facility progressing slower than expected,” Gilmer said.
Rubicon reported third-quarter revenue of $18.3-million, up 17% year-over-year but below Gilmer’s $20.7-million forecast and consensus of $20.3-million. Adjusted EBITDA reached $1.4-million, compared with his $2.6-million estimate and $1.7-million a year earlier. The Adjusted EBITDA margin was 7.9%, while adjusted gross margin declined to 27.5% from 33.7% a year earlier.
Cascadia generated approximately $2.3-million in revenue during the quarter, with the slower production increase contributing to higher costs. However, management remains confident in the facility’s production potential, while output at Pacifica has increased approximately 16% this year. Rubicon expects combined annual cultivation capacity to reach approximately 20,000 kilograms by mid-2027.
The company maintained its position as Canada’s leading premium licensed cannabis producer, with a 6.6% national market share in the premium segment. It also held 9.7% of premium flower sales and 4.9% of pre-roll sales. International revenue represented 11.7% of quarterly sales, with management targeting approximately 15% in 2027.
Gilmer said production improvements should support stronger margins in the second half of next year, although near-term profitability will remain below his previous expectations.
“Following the results and commentary from management, we have made a few changes to our model with the slower ramp of the Cascadia facility,” he said. “For 2027, our revenue estimate is relatively unchanged as the slower Cascadia ramp is slightly offset with the increase at Pacifica in the back half of the year while we have tempered our margins in H1/27.”
Gilmer reduced his fiscal 2026 revenue forecast to $68.8-million from $76.2-million and his Adjusted EBITDA estimate to $3.4-million from $7.2-million. His expected loss per share increased to $0.04 from approximately breakeven. For fiscal 2027, he raised his revenue forecast slightly to $88.6-million from $87.7-million but reduced Adjusted EBITDA to $11.9-million from $15.3-million. His earnings-per-share estimate declined to $0.03 from $0.07.
Rubicon ended September with $4.2-million in cash and approximately $13.8-million in outstanding debt, after generating $3.8-million in operating cash flow during the quarter.
Despite the forecast reductions, Gilmer said the company’s established brands and additional cultivation capacity support his longer-term outlook. “Rubicon continues to have strong market share within the premium segment across its markets,” he said. “The company remains prudent in operating expenses with a solid balance sheet. The acquisition of the new facility will help drive continued growth next year. We believe the company is positioned to establish itself in a strong niche segment of the market.”
-30-
Rod Weatherbie
Writer
Rod Weatherbie is a journalist based in Prince Edward Island. Since 2004, he has written extensively about the Canadian property and casualty insurance landscape. He was also a founder and contributing editor for a Toronto-based arts website and a PEI-based food magazine. His fiction and poetry have been featured in The Fiddlehead, The Antigonish Review, and Juniper.
